0001127602-12-028329.txt : 20121005
0001127602-12-028329.hdr.sgml : 20121005
20121005162440
ACCESSION NUMBER: 0001127602-12-028329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121003
FILED AS OF DATE: 20121005
DATE AS OF CHANGE: 20121005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAGEMANN ROBERT
CENTRAL INDEX KEY: 0001222676
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 121132612
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-10-03
0001022079
QUEST DIAGNOSTICS INC
DGX
0001222676
HAGEMANN ROBERT
C/O QUEST DIAGNOSTICS INCORPORATED
3 GIRALDA FARMS
MADISON
NJ
07940
1
SVP & Chief Financial Officer
Common Stock
2012-10-03
4
M
0
46667
40.4275
A
201233
D
Common Stock
2012-10-03
4
S
0
46667
64.00
D
154603
D
Common Stock
1781
I
SDCP
Stock Options (Right to Buy)
40.4275
2012-10-03
4
M
0
46667
0
D
2014-02-19
Common Stock
46667
46667
D
The exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on January 26, 2012.
The amount includes exempt purchases made under the Company's stock purchase plan
since the date of the last filing on Form 4.
These underlying shares were acquired on a periodic basis by the trustee of the Company's Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments), divided by the market price of the Company's stock as of that date.
The options vested in three annual installments on February 19, 2005, February 19, 2006 and February 19, 2007.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Robert Hagemann
2012-10-05